SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014408
Filing Date
2023-08-10
Accepted
2023-08-10 07:55:31
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20230630x10q.htm   iXBRL 10-Q 1554363
2 EX-31.1 mrns-20230630xex31d1.htm EX-31.1 13390
3 EX-31.2 mrns-20230630xex31d2.htm EX-31.2 13898
4 EX-32.1 mrns-20230630xex32d1.htm EX-32.1 7709
5 GRAPHIC mrns-20230630x10q004.jpg GRAPHIC 14134
6 GRAPHIC mrns-20230630x10q007.jpg GRAPHIC 68551
7 GRAPHIC mrns-20230630x10q008.jpg GRAPHIC 31531
  Complete submission text file 0001558370-23-014408.txt   6923408

Data Files

Seq Description Document Type Size
8 EX-101.SCH mrns-20230630.xsd EX-101.SCH 55809
9 EX-101.CAL mrns-20230630_cal.xml EX-101.CAL 53625
10 EX-101.DEF mrns-20230630_def.xml EX-101.DEF 184277
11 EX-101.LAB mrns-20230630_lab.xml EX-101.LAB 462819
12 EX-101.PRE mrns-20230630_pre.xml EX-101.PRE 315412
61 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20230630x10q_htm.xml XML 1024348
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 231157229
SIC: 2834 Pharmaceutical Preparations